title: Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery.
abstract: HeartWare continuous flow ventricular assist devices (HVAD) configured as biventricular assist devices maintain diurnal flow variation, lead to end-organ recovery, and provide for a successful bridge-to-heart transplantation in the first successful North American use of continuous flow biventricular assist devices.
authors: Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611-2968, USA. emcgee@nmh.org
authors: Edwin C
authors: EC
authors: McGee
authors: Umraan
authors: U
authors: Ahmad
authors: Daniel
authors: D
authors: Tamez
authors: Michael
authors: M
authors: Brown
authors: Neil
authors: N
authors: Voskoboynikov
authors: Sukit Chris
authors: SC
authors: Malaisrie
authors: Richard
authors: R
authors: Lee
authors: Patrick M
authors: PM
authors: McCarthy
mesh_terms: D000328:Adult; D016638:Critical Illness; D004638:Emergency Treatment / Q000379:methods; D004867:Equipment Design; D004869:Equipment Safety; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000379:methods*; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D018570:Risk Assessment; D012770:Shock, Cardiogenic / Q000175:diagnosis* / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D020257:Ventricular Remodeling / Q000502:physiology*; D014850:Waiting Lists